Open AccessTreatment of Severe Refractory Thrombocytopenia in Brucellosis with Eltrombopag: A Case Report
Author(s) -
Xianwen Zhang,
Peng Ren,
Ti-Long Huang
Publication year - 2022
Publication title -
the pediatric infectious disease journal/the pediatric infectious disease journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.028
H-Index - 140
eISSN - 1532-0987
pISSN - 0891-3668
DOI - 10.1097/inf.0000000000003555
Subject(s) - eltrombopag , brucellosis , refractory (planetary science) , medicine , immune thrombocytopenia , platelet , pediatrics , surgery , immunology , physics , astrobiology
Brucellosis is a zoonotic disease. Severe refractory thrombocytopenia caused by brucellosis is very rare and easily misdiagnosed. We reported a 5-year-old girl who developed severe refractory thrombocytopenia secondary to brucellosis. The first-line treatment including corticosteroids and intravenous immunoglobulin did not elevate her platelets, but eltrombopag worked well and her platelet count recovered rapidly.